the cadieux-léger fellowship, now in its 23rd year, provides direct experience in a policy research environment focused on the diverse challenges facing canadian foreign policy. the cadieux-léger fellow is integrated in the foreign policy research division at dfatd as a full-fledged analyst.  

the fellow's work includes some research related to priority topics, writing short papers, contributing to the operational policy requirements, including by networking with internal and external experts and contributing to policy working groups.

while at dfatd, the fellow is expected to advance canadian foreign policy and the foreign policy research division's research agenda, which includes themes such as:

1. evolving global governance: including the management of complex crises, the role of non-state actors, urbanization and the role of cities, and the future of diplomacy;
2. global threats, including terrorism;
3. strategic partnerships: including with asia, the united states and mexico;
4. technology and foreign policy: including the internet economy, implications of emerging technologies, and innovation diplomacy.

we welcome proposals in areas beyond these themes which have clear relevance to canadian foreign policy priorities, such as economic prosperity and international security. recent examples of past research topics include: natural resources, science diplomacy, religion and human rights, the future of russia, state capitalism, and prospects for africa. the relevance and quality of the research proposal is an important factor in the selection process.

through the institute community support (ics) program, the cihr institutes are launching the ics travel awards competition for 世界杯2022赛程表淘汰赛 , postdoctoral fellows, new investigators and knowledge users to present their own research at national and international meetings and/or conferences.

this ics travel awards competition will not support travel for research skills development or update, exchange programs or lectureships.

the specific objective of this funding opportunity is:

• to provide travel awards to individuals in aid of research and knowledge translation activities consistent with cihr institutes’ vision, mandate and strategic directions where the circumstances fall outside cihr's current suite of funding programs.

the specific objectives of this funding opportunity are to support innovative research projects relating to ebola virus disease (evd) with achievable outcomes, and with strong potential to have an impact on the management of evd in the current outbreak, or to prevent or improve the response to potential future evd outbreaks, by the end of the funding period.

relevant research areas

cihr will provide funding for applications that are determined to be relevant to the following research areas:

• ebola biology specifically in the areas of disease pathophysiology and virus replication
• ebola treatment, specifically in the areas of: antivirals, novel compounds, biologicals, convalescent plasma, rehydration and electrolyte replacement, clinical management of severe acute disease)
• transmission, spread, containment and prevention of ebola, specifically in the areas of: vaccines; rapid diagnostic technologies; development of enhanced early warning, mathematical modeling, and enhanced disease mapping methods; evaluating the effectiveness of preventive and containment measures to contain or prevent the spread of ebola
• study of the impacts of the ebola crisis on health system utilization patterns by different population groups in affected regions; the cost-effectiveness of health system resource development strategies in response to the ebola crisis; the sustainability of health workforce and other health system resource allocation strategies once the ebola crisis subsides.

the objective of this call is to support innovative and interdisciplinary research into the drivers to, and constraints on, extending working life. research is expected to cross the traditional boundaries of government departments and occupational sectors and to examine the implications of extending working life for older workers (50+), new labour markets, health, wellbeing and intergenerational equity.

in this context, this call invites proposals for funding research into one or more of four broad topics:

1. modern work factors
2. longer working life & inequality
3. health challenges
4. caring responsibilities

for cihr, it is mandatory that the canadian component of proposals address cihr’s mandate to support health research.

in the context of improved health for canadians, the objectives of collaborative health research projects (chrp) are to:

• translate research results to knowledge/technology users and other stakeholders;
• encourage the natural sciences or engineering and health research communities to collaborate and integrate their expertise;
• advance interdisciplinary research leading to knowledge and technologies with the potential to benefit canada by improving the canadian healthcare system and/or services and where appropriate lead to economic opportunities in canada; and
• train highly qualified personnel in collaborative and interdisciplinary research of relevance to health, while preparing them for employment opportunities in the private, public or not for profit sectors.

the purpose of this funding opportunity is to create a registry of dohad cohort studies that will provide a database of metadata and definition of variables from all relevant canadian cohorts, thereby linking them in a way that facilitates larger and better powered studies.

the specific objectives of the registry are to:

• create a user-friendly, effective platform to support data interoperability and improve harmonization practices;
• accelerate research and reduce cost by leveraging collaborative and/or cross-disciplinary research among canadian researchers and their international collaborators;
• broaden research perspectives by enabling national and international large-scale collaborative analyses.

the goal of the fy15 lcrp is to eradicate deaths from lung cancer to better the health and welfare of military service members, veterans, their families, and the american public. as such, the lcrp will support and integrate research from multiple disciplines for risk assessment, prevention, early detection, diagnosis, and treatment for the control and cure of lung cancer.

funding programs associated with this call:

• career development award
• clinical exploration award
• idea development award

the weston brain institute is delighted to launch our rapid response 2015 program to provide seed funding for totally novel, high-risk, high-reward translational research. additional information about the program can be found at http://westonbraininstitute.ca/funding-opportunities/2015-rapid-response/. 

goal:              provide seed funding for totally novel, high-risk, high-reward translational research ideas to catalyze the development of safe and effective treatments for neurodegenerative diseases of aging

funding:         up to $150,000 over 12-18 months

eligibility:       applicants must be researchers or postdoctoral fellows, and developing a therapeutic and/or a tool to help accelerate the development of therapeutics for neurodegenerative diseases of aging

dates:              program information session:          wednesday, may 20^th, 2015, 1:00 p.m. edt

                        letter of intent deadline:                  tuesday, june 16^th, 2015, 2:00 p.m. edt

submission of the letter of intent is done through the institute’s online grant management system at https://weston.smartsimple.ca/welcome/neuroscience.

the weston brain institute will be holding a program information session for this funding opportunity on may 20^th at 1:00 pm. this session is intended to provide you with comprehensive information on the application process and to provide an opportunity for open questions.  

to sign-up for the webex and receive the dial in details as well as submit any questions you may have in advance, please follow the link https://www.surveymonkey.com/s/yx22tjs

the institute welcomes inquiries about our funding programs at neuro@weston.ca or 416-935-4056.

the fiscal year 2015 (fy15) defense appropriations act provides $247.5 million to the department of defense peer reviewed medical research program (prmrp).  the vision of the prmrp is to improve the health and well-being of all military service members, veterans, and beneficiaries.  the prmrp challenges the scientific and clinical communities to address one of the fy15 congressionally directed topic areas with original ideas that foster new directions in basic science and translational research; novel product development leading to improved therapeutic or diagnostic tools; synergistic, multidisciplinary research program; or clinical trials that address an immediate clinical need.

as directed by the office of the assistant secretary of defense for health affairs, the defense health agency, research, development, and acquisition (dha rda) directorate manages and executes the defense health program (dhp) research, development, test, and evaluation (rdt&e) appropriation.  the executing agent for the anticipated program announcements/funding opportunities is the congressionally directed medical research programs (cdmrp).

fy15 prmrp program announcements and general application instructions are posted on grants.gov. 

military relevance:  relevance to the healthcare needs of the military service members, veterans, and beneficiaries is a key feature of each fy15 prmrp award mechanism.

clinical trial award – pre-application due june 18, 2015

assistant professor level or above (or equivalent)

·     supports the rapid implementation of clinical trials of novel interventions with the potential to have a significant impact on patient care in the topic area(s) of interest

·     proposed projects may range from small proof-of-concept trials through large-scale, definitive trials

·     investigational new drug or investigational device exemption applications, if needed, should be submitted to the food and drug administration before the prmrp grants.gov application submission deadline

preproposal submission is required; application submission is by invitation only

·   funding limit not defined; requested funding must be appropriate for the scope of work proposed

maximum period of performance is 5 years

discovery award – letter of intent due june 25, 2015

all investigators

·     supports the exploration of a highly innovative new concept or untested theory

·     not intended to support the logical progression of an already established line of questioning

·     clinical trials will not be funded

reviewers will be blinded to the identity of the pi, collaborators, and their organization(s)

·   maximum of $200,000 for direct costs (plus indirect costs)

maximum period of performance is 18 months

focused program award – pre-application due june 18, 2015

full professor level or above (or equivalent)

•restricted to the topic areas of acupuncture, advanced prosthetics, burn pit exposure, cardiovascular heart disease, congenital heart disease, focal segmental glomerulosclerosis, healthcare-acquired infection reduction, hepatitis b, hydrocephalus, integrative medicine, metals toxicology, mitochondrial disease, nanomaterials for bone regeneration, osteoarthritis, pathogen-inactivated dried plasma, pulmonary fibrosis, psychotropic medications, respiratory health, sleep disorders, vascular malformations, and women’s heart disease

•supports a synergistic, multidisciplinary research program of at least four distinct but complementary projects addressing an overarching goal in one of the topic areas listed directly above

•projects should work together to answer critical questions, resolve differing hypotheses, and translate laboratory findings to clinical applications

•projects may range from exploratory/hypothesis-developing through small-scale clinical trials that together will address the overarching goal/question

•research team of highly qualified, multidisciplinary project leaders should be led by a principal investigator with demonstrated success in directing large, focused projects

preproposal submission is required; application submission is by invitation only

·   maximum of $10 million for total costs (includes direct and indirect costs)

·   maximum period of performance is 5 years

investigator-initiated research award – pre-application due june 11/2015

assistant professor level or above
(or equivalent)

·     supports research that will make an original and important contribution to the field of research or patient care in the topic area(s) of interest

·     partnering principal investigator (pi) option available

·     clinical trials will not be funded

preproposal submission is required; application submission is by invitation only

·   maximum of $1.2 million for direct costs (plus indirect costs)

·   maximum of $1.5 million for direct costs (plus indirect costs) for applications including a partnering pi option

maximum period of performance is 3 years

technology/ therapeutic development award – pre-application due june 11, 2015

assistant professor level or above
(or equivalent)

·     supports the development of diagnostics or therapies that have the potential to make a strong impact on patient care in the topic area(s) of interest

·     product-oriented: device, drug, clinical guidelines

·     clinical trials will not be funded

preproposal submission is required; application submission is by invitation only

·   maximum of $1.8 million for direct costs (plus indirect costs)

maximum period of performance is 3 years

clinical trial award – pre-application due june 10, 2105

investigators at or above the level of associate professor (or equivalent)

·       supports research with the potential to have a major impact on the treatment and/or management of autism spectrum disorder (asd).

·       preliminary data relevant to the proposed project are required.

pre-application is required; application submission is by invitation only.

·        behavioral, cognitive, and other non-pharmacological therapies

·        pharmacological treatments in autism or well-defined subgroups of autism

·        dissemination/implementation of efficacious behavioral interventions (including measures of fidelity and outcomes)

therapies to alleviate conditions co-occurring with asd (e.g., sleep disturbances, gastrointestinal issues, aggression, depression, anxiety)

·         maximum funding for the entire period of performance is $1,000,000 in direct costs (plus indirect costs)

maximum period of performance is 4 years

idea development award – pre-application due june 10, 2015

investigators at or above the level of assistant professor (or equivalent)

·       supports the development of innovative, high-impact ideas that advance the understanding of asd and ultimately lead to improved outcomes.

·       preliminary data are required.

·       multiple principal investigator (pi) option:  up to two investigators may collaborate on a single application, each of whom will be recognized as a pi and receive a separate award.

pre-application is required; application submission is by invitation only.

·        assessment of novel therapeutics using valid preclinical models

·        environmental risk factors

·        mechanisms of heterogeneous clinical expression of asd

·        mechanisms underlying conditions co-occurring with asd (e.g., sleep disturbances, gastrointestinal issues, aggression, depression, anxiety)

factors promoting success in key transitions to independence for individuals living with asd

·         maximum funding for the entire period of performance is $340,000 in direct costs (plus indirect costs)

·         for multiple pis, the combined funding for all pis for the entire period of performance may not exceed $340,000 in direct costs (plus indirect costs)

maximum period of performance is 3 years